Testing for COVID-19 in Rheumatology
In this interview with Rheumatology Network, Dr. Andrew Concoff, executive vice president and chief value officer of United Rheumatology, addresses COVID-19 testing for rheumatology patients.
 
Hydroxychloroquine Not Recommended for COVID-19 by NIH
This week the National Institutes of Health issued treatment guidelines for the management of COVID-19. It does not include the use of pharmaceutical agents for pre or post-exposure prophylaxis, including hydroxychloroquine, except within the confines of a clinical trial. This comes as good news to the rheumatology community. More in this article.
 
Early Data is in for the COVID-19 Rheumatology Registry
The international registry that was created in March to track rheumatology patients who have contracted COVID-19, has released data from the first 110 cases from six continents.
 
Osteoporosis Treatments Feared and Underused
Despite an apparent and increasing need for osteoporosis treatments, fewer people today are taking the medications both here in the United States and abroad.
 
Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.